Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations - Drug Trials For Money - Paid Clinical Trials

A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations

A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
Condition:   Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
Intervention:   Drug: Trastuzumab deruxtecan
Sponsors:   AstraZeneca;   Daiichi Sankyo Co., Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 25, 2021 / by / in
Comments